Despite these recent advances, the oncogenic signaling modules targeted by aberrant FAK expression and activity in developing and progressing breast cancers, and their potential role in regulating the activity and composition of associated tumor stroma remain to be fully defined. The gene discussed is PTK2; the disease is breast cancer.